ANADROL-50 (Oxymetholone) by Meditech is a pharmaceutical-grade oral anabolic-androgenic steroid formulated at 50 mg per tablet, supplied in sachets of 100 tablets or blister packs of 2 × 50 tablets. Oxymetholone is a 17α-alkylated DHT-derived anabolic-androgenic compound with an extensive clinical and pharmacological research history, documented as one of the most potent oral anabolic-androgenic steroids in comparative steroid pharmacology literature in terms of rapid lean mass accrual and strength parameter effects per unit dose. Oxymetholone holds established clinical documentation for therapeutic applications in anemia management and muscle wasting conditions, representing a well-characterized compound across both clinical medicine and anabolic pharmacology research literature.
 
✔ Key Research Insights
Studied for its role in enhancing protein synthesis and nitrogen retention in research subjects, with documented rapid and pronounced effects on lean mass parameters and strength indices among the most potent documented in comparative oral anabolic-androgenic steroid research
Investigated for its pronounced erythropoietic activity, with documented stimulation of red blood cell production representing one of the primary established clinical research applications of oxymetholone in anemia pharmacotherapy literature
Researched for its influence on recovery markers and training intensity parameters across documented subject populations in anabolic research literature
Examined for its estrogenic activity profile — notably documented in research literature as exhibiting estrogenic effects despite its DHT-derived structure, through mechanisms not involving aromatization but rather direct estrogenic receptor activity — with associated fluid retention and estrogenic sequelae referenced as pharmacologically relevant clinical considerations
Documented for its 17α-alkylated oral bioavailability, with hepatotoxic considerations referenced as particularly clinically relevant in oxymetholone research protocols relative to other oral anabolic compounds, given its documented hepatotoxic potential at therapeutic doses in clinical literature
Researched for its established therapeutic applications in aplastic anemia, HIV/AIDS-associated wasting, and osteoporosis management, representing well-characterized clinical documentation across internal medicine and hematology literature
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: ANADROL-50
Molecule: Oxymetholone
Concentration: 50 mg per tablet
Appearance: Purple octagon-shaped tablet imprinted with logo "M"
Packing: 100 tablets per sachet or 2 × 50 tablet blister packs
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Oxymetholone is a 17α-alkylated DHT-derived anabolic-androgenic steroid administered orally. The 17α-alkylation modification confers resistance to hepatic first-pass metabolism, enabling consistent oral bioavailability and predictable systemic availability following gastrointestinal absorption in research subjects. This structural modification is concurrently associated with hepatotoxic potential documented in clinical literature as a particularly significant consideration in oxymetholone research protocols, with hepatic function monitoring referenced consistently across clinical literature for subjects receiving oxymetholone at therapeutic doses. Oxymetholone exerts its primary anabolic effects through androgen receptor binding in muscle tissue, with downstream influences on protein synthesis and nitrogen retention producing characteristically rapid and pronounced lean mass accrual documented in comparative oral anabolic steroid research. A pharmacologically notable and extensively discussed characteristic of oxymetholone in research literature is its documented estrogenic activity — despite being DHT-derived and therefore theoretically non-aromatizable — with fluid retention, gynecomastia risk, and other estrogenic sequelae consistently documented in clinical observations. The precise mechanism of oxymetholone's estrogenic activity remains an area of pharmacological research interest, with direct estrogen receptor agonism proposed as the primary mechanism in comparative steroid pharmacology literature, as standard aromatase inhibition has been documented as incompletely effective in managing oxymetholone-associated estrogenic effects. Its well-documented erythropoietic activity — stimulating red blood cell production via erythropoietin-dependent and independent pathways — forms the basis of its established clinical therapeutic application in aplastic anemia and anemia associated with myelofibrosis and other hematological conditions referenced in internal medicine and hematology literature.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
One of the most potent oral anabolic-androgenic compounds documented in comparative steroid pharmacology literature, with particularly pronounced rapid lean mass accrual and strength parameter effects per unit dose
Established clinical therapeutic applications in aplastic anemia, HIV/AIDS-associated wasting, and osteoporosis management documented across hematology and internal medicine literature
Distinctively identified purple octagon tablet presentation at 50 mg per tablet for consistent product recognition
Available in both sachet and blister pack formats providing 100 tablets per unit
Widely referenced in anabolic pharmacology, hematology, and clinical medicine research literature under the oxymetholone and Anadrol designations